| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |